Ledger.Open graph →
SEC Form D · filed August 14, 2020

Aerovate Therapeutics, Inc

Offering
$75.8M
Sold
$75.8M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Maha T. Katabi · San Diego, CADirectorJoshua T. Resnick · Boston, MADirectorDavid T. Grayzel · Boston, MADirectorBenjamin T. Dake · Boston, MAExec · DirectorJonathan T. Leff · Boston, MADirectorMaha T. Katabi · San Diego, CADirectorBenjamin T. Dake · Boston, MAExec · DirectorJoshua T. Resnick · Boston, MADirectorJonathan T. Leff · Boston, MADirectorDavid T. Grayzel · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗